Atlas Trials

THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)

Clinical trial NCT02002325 · UNKNOWN

Trial details

NCT number
NCT02002325
Sponsor
National Cerebral and Cardiovascular Center, Japan
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Stroke
Start date
2014-05-01
Primary completion
2019-12-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.